hero-654791312-sized

Ensights

Science that is transforming lives and enabling the future

Critical Factors in Achieving a Strong Supply Chain for Your Cell and Gene Therapy

All Posts

Critical Factors in Achieving a Strong Supply Chain for Your Cell and Gene Therapy

Are you looking for a supply partner to help you scale cell and gene therapy (CGT) manufacturing? Do you need a partner that can help you keep up with pre-existing capacity increases? These challenges may lead to some hard choices.

CGT is an emerging field. Its products are neither simple nor inexpensive. Their precursors require a specialized supply chain with products for both the blood and bioprocessing industries. This means that your ideal supplier may be difficult to find.

What to Look For in a CGT Supplier

Patients depend on CGT to solve life-threatening medical issues. Supply bottlenecks, quality issues, and communication problems can impact more than your bottom line. The best suppliers won’t just deliver a product. Instead, they’ll actively collaborate with you, altering their existing materials to provide the best match for your processes.

When you’re looking for a CGT supplier, it’s important to find a partner that meets the following criteria:

  • Able to scale alongside a growing industry
  • Meets stringent quality and purity requirements
  • Understands and complies with regulatory requirements
  • Provides expertise in handling complex customer support requests

Best-in-Class CGT Suppliers Deliver Availability and Flexibility

Critical materials availability is one of the most important aspects of a strong CGT supply chain. These materials include things like cell culture media, viral vectors, and gene delivery devices. They must be of the highest quality and available when needed to ensure the success of CGT treatments. Ensuring proper transport and care is essential to the viability of these fragile components. If a bag thaws or gets compromised, then what?

Another important aspect of a strong CGT supply chain is the flexibility to adapt to changes in demand. This is because the demand for CGT products is expected to grow rapidly in the coming years. Suppliers must be able to quickly increase production to meet this demand.

Lastly, suppliers should be able to ensure a consistent and high-quality supply of materials that might ordinarily be considered generic. One example of this is PVC tubing, which is one of the key components of a strong and reliable cell and gene therapy supply chain. This versatile material is easy to use for transferring cells and fluids, while also making it ideal for use with cell and gene therapy production. Any shortage could force CGT producers to seek lower-quality alternatives, or halt production altogether. Therefore, the ideal CGT supplier can provide both high-quality precursors and more fundamental materials.

Ensuring Continuity of Production for CGT

Here is some advice for building a strong CGT supply chain:

  • Choose suppliers that have a proven track record of reliability and flexibility; look at how they performed during the coronavirus crunch.
  • Establish open lines of communication with your suppliers so that you can quickly respond to changes in demand; assess whether they return your emails or quotes in a timely manner
  • Conduct regular audits of your suppliers to ensure that they are meeting your quality standards
  • Build a contingency plan in case of a supply disruption; look at potential backup suppliers

By taking these steps, you can help to ensure that your CGT treatments are safe and effective. Learn more about how we can help you avoid costly pitfalls here.

 

 

 

 

Related Posts

Entegris Offers New FOUP Form-Factors for Non-Standard Wafers

Entegris Offers New FOUP Form-Factors for Non-Standard Wafers Over the last few years, 3D stacking has gone from a relatively niche fabrication method to an absolute necessity for cutting-edge applications. As chipmakers delve into smaller and smaller nodes, stacking and die-bonding wafers has become a preferred way of creating more processing power in a smaller space. Stacked and bonded wafers don’t behave the same way as 2D wafers: Wafers are thinned prior to bonding, which results in wafers that can sag when handled Bonded wafers are thicker and heavier than 2D wafers when assembled Bonded wafers can also warp following assembly Many automation tools rely on the predictable geometry and characteristics of 2D silicon wafers for safe handling and transport. While stacked and bonded wafers are a game-changer for miniaturization, they can also force manufacturing compromises unless chipmakers adopt specialized tools for the back end of the line (BEOL).

Mastering the SiC Wafer Transition

The use of silicon carbide (SiC) semiconductors offers a huge advantage for electric vehicles (EVs) due to lower switching losses and higher efficiencies, but cost has always been a drawback. SiC wafer manufacturing can suffer from high costs and lower yields, causing SiC semiconductors to cost up to eight times more than their silicon equivalents. This cost often gets passed on to the end customer, making EVs more expensive.

What is the Inkjet Cartridge Effect in Air Filtration Performance?

A “one size fits all” approach for chemical air filtration entails a productivity and safety risk in commercial environments reliant on pure air quality. Trying to use one type of chemical air filter for every scenario may provide protection, but without optimization the protection is both limited and temporary.